# Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers

> **NCT03028285** · PHASE1 · COMPLETED · sponsor: **POLYSAN Scientific & Technological Pharmaceutical Company** · enrollment: 48 (actual)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DRUG:** arginine sodium succinate

## Key facts

- **NCT ID:** NCT03028285
- **Lead sponsor:** POLYSAN Scientific & Technological Pharmaceutical Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-15
- **Primary completion:** 2017-01-19
- **Final completion:** 2017-01-26
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2020-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03028285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03028285, "Study of Safety and Tolerability of UNIFUZOL (Solution for Infusions) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03028285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*